MICHAEL JONATHAN E - 20 May 2026 Form 4 Insider Report for SS&C Technologies Holdings Inc (SSNC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 May 2026, 16:38:29 UTC
Prior SEC filing
17 Jun 2025
Next SEC filing
17 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jason White, Attorney-in-fact for Jonathan E. Michael

Key filing fact

MICHAEL JONATHAN E filed Form 4 for SS&C Technologies Holdings Inc (SSNC) on 22 May 2026.

Key facts

  • This page summarizes MICHAEL JONATHAN E's Form 4 filing for SS&C Technologies Holdings Inc (SSNC).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 22 May 2026, 16:38.

Change

  • Previous filing in this sequence was filed on 17 Jun 2025.
  • Current net transaction value: -$183,196.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001192701 Primary reporting owner

MICHAEL JONATHAN E

Relationship
Director
Address
C/O SS&C TECHNOLOGIES HOLDINGS, INC., 80 LAMBERTON ROAD, WINDSOR
Signature
Jason White, Attorney-in-fact for Jonathan E. Michael
Signature date
22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SSNC transaction

Common Stock

Options Exercise

Transaction value
Shares
+6,000
Change %
+7.9%
Price
$30.44*
Shares after
82,124
Date
20 May 2026
Ownership
Direct
SSNC transaction

Common Stock

Sale

Transaction value
$183,196
Shares
-2,740
Change %
-3.3%
Price
$66.86
Shares after
79,384
Date
20 May 2026
Ownership
Direct
SSNC transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,580
Change %
+3.3%
Price
Shares after
81,964
Date
20 May 2026
Ownership
Direct
Footnotes
F1, F2
SSNC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
67,679
Date
20 May 2026
Ownership
Through trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SSNC transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-6,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
20 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,000
Exercise price
$30.44
Footnotes
F3
SSNC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-2,580
Change %
-100%
Price
$0.000000*
Shares after
0
Date
20 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,580
Exercise price
Footnotes
F1, F2
SSNC transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+3,200
Change %
Price
$0.000000*
Shares after
3,200
Date
20 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,200
Exercise price
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the vesting of restricted stock units granted to the reporting person on May 21, 2025, together with 33 dividend equivalent rights accrued thereon.

Footnote F2

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F3

The stock option was fully vested as of the date of the grant.

Footnote F4

The restricted stock units vest 100% on the earlier of (i) the first anniversary of the grant date and (ii) the date of the issuer's annual general meeting of stockholders held in fiscal 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .